Drugs / IPV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03016949 | Jul 2017 → Oct 2018 | poliomyelitis | Fidec Corporation | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03016949 ↗ |
| Modality | Vaccine | “full dose inactivated polio vaccines (IPV)” NCT03016949 ↗ |
| Route | Intramuscular | “via intramuscular administration (IM)” NCT03016949 ↗ |